Table 2.
Group | Experimental group | Vaccine | α-GalCer (μg/kg) | Challenge virusc | N |
---|---|---|---|---|---|
1 | Mock – Mock | Vehiclea | Vehicleb | - | 2 |
2 | Mock – TX98 | Vehicle | Vehicle | H3N2 TX98 | 6 |
3 | Mock – CA04 | Vehicle | Vehicle | H1N1 CA04 | 6 |
4 | TX98ΔNS1 – TX98 | TX98ΔNS1 | Vehicle | H3N2 TX98 | 6 |
5 | TX98ΔNS1 – CA04 | TX98ΔNS1 | Vehicle | H1N1 CA04 | 6 |
6 | TX98ΔNS1 αGC – CA04 | TX98ΔNS1 | 50 | H1N1 CA04 | 6 |
aVirus-free DMEM
b25 μL/kg of DMSO (the volume used to dissolve the 50 μg/kg dose of α-GalCer used in group 6)
c1 x 106 TCID50 H3N2 A/Swine/Texas/4199-2/1998 or H1N1 A/California/04/2009 administered i.t. in 2 mL of DMEM